We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,306
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RCMT icon
7326
RCM Technologies
RCMT
$206M
$9K ﹤0.01%
3,000
-61
-2% -$175
REFR icon
7327
Research Frontiers
REFR
$16.3M
$9K ﹤0.01%
2,998
+45
+2% +$144
SNFCA icon
7328
Security National Financial
SNFCA
$247M
$9K ﹤0.01%
2,101
-2,393
-53% -$8.72K
SSKN
7329
DELISTED
Strata Skin Sciences
SSKN
$9K ﹤0.01%
427
+302
+242% +$6.86K
STG
7330
Sunlands Technology
STG
$42.7M
$9K ﹤0.01%
281
+110
+64% +$3.59K
TIGO icon
7331
Millicom
TIGO
$15.4B
$9K ﹤0.01%
180
+170
+1,700% +$7.8K
TTT icon
7332
ProShares UltraPro Short 20+ Year Treasury
TTT
$18.7M
$9K ﹤0.01%
+142
New +$8.85K
DMDV
7333
DELISTED
AAM S&P Developed Markets High Dividend Value ETF
DMDV
$9K ﹤0.01%
+300
New +$7.65K
TCON
7334
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$9K ﹤0.01%
187
+153
+450% +$10.1K
THMO
7335
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
$9K ﹤0.01%
47
+43
+1,075% +$8.29K
SPXB
7336
DELISTED
ProShares S&P 500 Bond ETF
SPXB
$9K ﹤0.01%
+107
New +$9.38K
MIXT
7337
DELISTED
MIX TELEMATICS LIMITED
MIXT
$9K ﹤0.01%
732
-1,028
-58% -$13K
FGH
7338
DELISTED
FG Group Holdings Inc.
FGH
$9K ﹤0.01%
2,680
+1,185
+79% +$3.34K
CYAN
7339
DELISTED
Cyanotech Corp
CYAN
$9K ﹤0.01%
3,844
+775
+25% +$1.83K
AENZ
7340
DELISTED
Aenza S.A.A.
AENZ
$9K ﹤0.01%
1,252
-679
-35% -$4.57K
BIOC
7341
DELISTED
Biocept, Inc.
BIOC
$9K ﹤0.01%
+102
New +$17.6K
AUTO
7342
DELISTED
AutoWeb, Inc. Common Stock
AUTO
$9K ﹤0.01%
3,615
-602
-14% -$1.56K
PAE
7343
DELISTED
PAE Incorporated Class A Common Stock
PAE
$9K ﹤0.01%
+894
New +$9.14K
TWNKW
7344
DELISTED
Hostess Brands, Inc. Warrants
TWNKW
$9K ﹤0.01%
4,548
+2,157
+90% +$3.25K
TLGT
7345
DELISTED
Teligent, Inc
TLGT
$9K ﹤0.01%
2,085
+1,635
+363% +$10.2K
SWI
7346
DELISTED
SolarWinds Corporation Common Stock
SWI
$9K ﹤0.01%
474
-3,045
-87% -$60.4K
SMEZ
7347
DELISTED
SPDR EURO STOXX Small Cap ETF
SMEZ
$9K ﹤0.01%
139
-52,379
-100% -$3.1M
DJPY
7348
DELISTED
Exchange-Traded Notes linked to the VelocityShares Daily 4X Long USD vs. JPY Index due December 6, 2
DJPY
$9K ﹤0.01%
369
-1
-0.3% -$24
ZOM
7349
DELISTED
Zomedica Corp.
ZOM
$9K ﹤0.01%
26,439
-36,675
-58% -$12.3K
FPAC.U
7350
DELISTED
Far Point Acquisition Corporation Units, each consisting of one share of Class A common stock, $0.00
FPAC.U
$9K ﹤0.01%
842
+95
+13% +$1.02K

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.